Use of Ipilimumab in Metastatic Castration-Resistant Prostate Cancer That Progressed After Docetaxel

JO Capsule - Ipilimumab after bone-directed radiotherapy failed to significantly prolong overall survival compared with placebo in the intent-to-treat analysis but showed evidence of antitumor activity and stronger benefit in patients with favorable prognostic factors.
Source: Clinical Care Options Prostate Cancer - Category: Cancer & Oncology Source Type: research